AU8016894A - Betaglycan polypeptides having tgf-beta binding activity - Google Patents

Betaglycan polypeptides having tgf-beta binding activity

Info

Publication number
AU8016894A
AU8016894A AU80168/94A AU8016894A AU8016894A AU 8016894 A AU8016894 A AU 8016894A AU 80168/94 A AU80168/94 A AU 80168/94A AU 8016894 A AU8016894 A AU 8016894A AU 8016894 A AU8016894 A AU 8016894A
Authority
AU
Australia
Prior art keywords
tgf
binding activity
beta binding
betaglycan polypeptides
betaglycan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80168/94A
Inventor
Ralf Butzow
Daikichi Fukushima
Erkki Ruoslahti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Publication of AU8016894A publication Critical patent/AU8016894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
AU80168/94A 1993-10-15 1994-10-14 Betaglycan polypeptides having tgf-beta binding activity Abandoned AU8016894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13836893A 1993-10-15 1993-10-15
US138368 1993-10-15
PCT/US1994/011648 WO1995010610A1 (en) 1993-10-15 1994-10-14 BETAGLYCAN POLYPEPTIDES HAVING TGF-β BINDING ACTIVITY

Publications (1)

Publication Number Publication Date
AU8016894A true AU8016894A (en) 1995-05-04

Family

ID=22481710

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80168/94A Abandoned AU8016894A (en) 1993-10-15 1994-10-14 Betaglycan polypeptides having tgf-beta binding activity

Country Status (2)

Country Link
AU (1) AU8016894A (en)
WO (1) WO1995010610A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174868T3 (en) * 1992-10-29 2002-11-16 Celtrix Pharma FRAGMENT OF THE FIXING RECEIVER TO TGF-BETA TIPOII AS A THERAPEUTIC AGENT.
GB2304045A (en) * 1995-08-04 1997-03-12 Univ Manchester Betaglycan compositions for promoting the healing of wounds and fibrotic diseases
WO2001043763A1 (en) 1999-12-15 2001-06-21 Research Development Foundation Betaglycan as an inhibin receptor and uses thereof
WO2005028517A2 (en) * 2003-05-09 2005-03-31 The General Hospital Corporation SOLUBLE TGF-β TYPE III RECEPTOR FUSION PROTEINS
MXPA03004172A (en) * 2003-05-13 2004-11-18 Univ Mexico Nacional Autonoma Treatment kit which assists with antibiotic therapy for intracellular infectious diseases.
GB0426960D0 (en) 2004-12-08 2005-01-12 Ares Trading Sa TGR-3 like protein receptor
WO2007050793A2 (en) 2005-10-25 2007-05-03 The Johns Hopkins University Methods and compositions for the treatment of marfan syndrome and associated disorders
EP1998810A4 (en) 2006-03-13 2009-09-02 Univ Johns Hopkins Augmentation of endothelial thromboresistance
HUE035575T2 (en) 2006-10-03 2018-05-28 Genzyme Corp Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia
CN103429732B (en) 2010-12-27 2015-09-16 Lsip基金运营联合公司 IPS cell and manufacture method thereof
EP2737083A1 (en) 2011-07-27 2014-06-04 INSERM (Institut National de la Santé et de la Recherche Scientifique) Methods for diagnosing and treating myhre syndrome
BR112014009789A2 (en) 2011-10-26 2017-04-25 Seattle Children's Res Inst cysteamine in the treatment of fibrotic disease
JP6218229B2 (en) 2011-12-28 2017-10-25 京都府公立大学法人 Normalization of corneal endothelial cell culture
US11382904B2 (en) 2013-10-31 2022-07-12 Kyoto Prefectural Public University Corporation Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
US10882903B2 (en) 2015-05-18 2021-01-05 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and compositions for treating an alphavirus infection
EP3947737A2 (en) 2019-04-02 2022-02-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010215A1 (en) * 1991-11-15 1993-05-27 Memorial Sloan-Kettering Cancer Center Purified proteoglycan betaglycan, compositions, and methods

Also Published As

Publication number Publication date
WO1995010610A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
AU1321895A (en) Binding assay
AU4370596A (en) Novel hedgehog-derived polypeptides
AU2662795A (en) Cdk4 binding proteins
AU7978694A (en) Catalytic dna
AU5283793A (en) Recombinant specific binding protein
AU2919197A (en) Flat antenna
ZA947122B (en) Drug binding protein.
AU5926194A (en) Catalyst composition
AU3216797A (en) Novel heparin binding peptides
AU2527497A (en) Puzzle book
AU1372795A (en) Catalyst composition
AU8016894A (en) Betaglycan polypeptides having tgf-beta binding activity
AU6472994A (en) Card
AU671148C (en) Binding element
GB9326451D0 (en) Binding assay
AU6939594A (en) Stapler
AU4312697A (en) Catalysts
AU5384596A (en) Binding assembly
AU3640397A (en) Ob protein binding protein
AU1235597A (en) Fibrinogen binding peptides
AU1475597A (en) Rapid-freezing container
AU4586497A (en) Calcium-integrin binding protein
AU8139594A (en) Microtome
AU3979397A (en) Container
AU2379397A (en) Container